It is interesting to note that while the aforementioned studies demonstrate the importance of Nox2-expressing inflammatory cells after stroke, studies investigating outcomes beyond the acute phase of stroke have found that compounds targeting inflammation can be effective with a short survival period, but these initial benefits may be lost over time [162,163]. Here, CYBB is linked to Stroke.